Giner-Galvañ, V.; Pomares-Gómez, F.J.; Quesada, J.A.; Rubio-Rivas, M.; Tejada-Montes, J.; Baltasar-Corral, J.; Taboada-MartÃnez, M.L.; Sánchez-Mesa, B.; Arnalich-Fernández, F.; Del Corral-Beamonte, E.;
et al. C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19. Biomedicines 2022, 10, 1393.
https://doi.org/10.3390/biomedicines10061393
AMA Style
Giner-Galvañ V, Pomares-Gómez FJ, Quesada JA, Rubio-Rivas M, Tejada-Montes J, Baltasar-Corral J, Taboada-MartÃnez ML, Sánchez-Mesa B, Arnalich-Fernández F, Del Corral-Beamonte E,
et al. C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19. Biomedicines. 2022; 10(6):1393.
https://doi.org/10.3390/biomedicines10061393
Chicago/Turabian Style
Giner-Galvañ, Vicente, Francisco José Pomares-Gómez, José Antonio Quesada, Manuel Rubio-Rivas, Javier Tejada-Montes, Jesús Baltasar-Corral, MarÃa Luisa Taboada-MartÃnez, Blanca Sánchez-Mesa, Francisco Arnalich-Fernández, Esther Del Corral-Beamonte,
and et al. 2022. "C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19" Biomedicines 10, no. 6: 1393.
https://doi.org/10.3390/biomedicines10061393
APA Style
Giner-Galvañ, V., Pomares-Gómez, F. J., Quesada, J. A., Rubio-Rivas, M., Tejada-Montes, J., Baltasar-Corral, J., Taboada-MartÃnez, M. L., Sánchez-Mesa, B., Arnalich-Fernández, F., Del Corral-Beamonte, E., López-Sampalo, A., Pesqueira-Fontán, P. M., Fernández-Garcés, M., Gómez-Huelgas, R., Ramos-Rincón, J. M., & on behalf of the SEMI-COVID-19 Network.
(2022). C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19. Biomedicines, 10(6), 1393.
https://doi.org/10.3390/biomedicines10061393
